Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Actas Urol Esp
1 Ann Saudi Med
1 Anticancer Res
1 BMC Urol
1 Br J Radiol
1 Can Urol Assoc J
1 Cancer Gene Ther
2 Cancer Sci
1 Cell Death Dis
1 Clin Genitourin Cancer
1 Dose Response
1 Epidemiology
1 Epigenomics
5 Eur Urol
2 Expert Rev Anticancer Ther
1 Front Oncol
1 Gene
1 Hereditas
1 Indian J Pathol Microbiol
1 Int Urol Nephrol
1 J Adv Pract Oncol
1 J Cancer
1 J Gastrointest Surg
1 J Hand Surg Am
1 J Pathol
1 J Trace Elem Med Biol
1 J Urol
1 JNCI Cancer Spectr
1 Nat Rev Urol
1 Oncol Lett
1 Oncologist
1 Pathol Int
1 Pract Radiat Oncol
1 Proc Natl Acad Sci U S A
1 Scand J Urol
1 Sci Rep
2 Ther Adv Urol
1 Urol Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Actas Urol Esp

  1. MINA S, Pardo Munevar CA, Osorio D, Garcia-Perdomo HA, et al
    Life quality evaluation in patients with bladder cancer: A systematic review.
    Actas Urol Esp. 2019 Jan 30. pii: S0210-4806(18)30230.
    PubMed     Text format     Abstract available

    Ann Saudi Med

  2. AL-DAGHMIN A, Alhamss S, Al-Najjar H, Al-Saidi I, et al
    Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment.
    Ann Saudi Med. 2019;39:42-47.
    PubMed     Text format     Abstract available

    Anticancer Res

  3. KUSUHARA Y, Daizumoto K, Kawai K, Hirayama K, et al
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
    Anticancer Res. 2019;39:703-711.
    PubMed     Text format     Abstract available

    BMC Urol

  4. FROEHNER M, Koch R, Hubler M, Heberling U, et al
    Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
    BMC Urol. 2018;18:91.
    PubMed     Text format     Abstract available

    Br J Radiol

  5. KONG V, Kwan M, Chen S, Chung P, et al
    Quantification of interobserver variability in image registration using conebeam CT for partial bladder radiotherapy - A Comparison between Lipiodol and Bladder Wall Surface.
    Br J Radiol. 2018 Nov 1:20180413. doi: 10.1259/bjr.20180413.
    PubMed     Text format     Abstract available

    Can Urol Assoc J

  6. RAPHAEL MJ, Booth CM
    Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49(th) parallel.
    Can Urol Assoc J. 2019;13:29-31.
    PubMed     Text format    

    Cancer Gene Ther

  7. ZHANG X, Liu X, Jing Z, Bi J, et al
    The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
    Cancer Gene Ther. 2019 Feb 6. pii: 10.1038/s41417-019-0085.
    PubMed     Text format     Abstract available

    Cancer Sci

  8. TSAI YS, Jou YC, Tsai HT, Shiau AL, et al
    Prothymosin-alpha Enhances PTEN Expression and Binds with TRIM21 to Regulate Keap1/Nrf2 Signaling in Human Bladder Cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13963.
    PubMed     Text format     Abstract available

  9. OGIHARA K, Kikuchi E, Okazaki S, Hagiwara M, et al
    Sulfasalazine may modulate the CD44v9-xCT system and enhance CDDP-induced cytotoxic effects in metastatic bladder cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13960.
    PubMed     Text format     Abstract available

    Cell Death Dis

  10. LIU YN, Zhang H, Zhang L, Cai TT, et al
    Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.
    Cell Death Dis. 2019;10:50.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  11. PAK S, You D, Jeong IG, Song C, et al
    Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 9. pii: S1558-7673(19)30008.
    PubMed     Text format     Abstract available

    Dose Response

  12. COTRUVO JA, Amato H
    National Trends of Bladder Cancer and Trihalomethanes in Drinking Water: A Review and Multicountry Ecological Study.
    Dose Response. 2019;17:1559325818807781.
    PubMed     Text format     Abstract available


  13. SIGNES-PASTOR AJ, Scot Zens M, Seigne J, Schned A, et al
    Rice Consumption and Incidence of Bladder Cancer in the United States Population.
    Epidemiology. 2019;30:e4-e5.
    PubMed     Text format    


  14. BOSSCHIETER J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, et al
    A two-gene methylation signature for the diagnosis of bladder cancer in urine.
    Epigenomics. 2019 Feb 1. doi: 10.2217/epi-2018-0094.
    PubMed     Text format     Abstract available

    Eur Urol

  15. CHOUDHURY A, Hoskin PJ
    Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.
    Eur Urol. 2019 Feb 4. pii: S0302-2838(19)30086.
    PubMed     Text format    

  16. EFSTATHIOU JA, Mouw KW, Gibb EA, Liu Y, et al
    Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30012.
    PubMed     Text format     Abstract available

  17. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30075.
    PubMed     Text format    

  18. RADZISZEWSKI P, Poletajew S
    Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-G
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30074.
    PubMed     Text format    

    Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?
    Eur Urol. 2018;74:754-755.
    PubMed     Text format    


  20. HU G, Wang X, Han Y, Wang P, et al
    Protein arginine methyltransferase 5 promotes bladder cancer growth through inhibiting NF-kB dependent apoptosis.
    EXCLI J. 2018;17:1157-1166.
    PubMed     Text format     Abstract available

    Expert Rev Anticancer Ther

  21. FREIFELD Y, Krabbe LM, Clinton TN, Woldu SL, et al
    Therapeutic strategies for upper tract urothelial carcinoma.
    Expert Rev Anticancer Ther. 2018;18:765-774.
    PubMed     Text format     Abstract available

  22. REDMAN JM, Madan RA
    Spotlight on atezolizumab and its potential as an oncology agent.
    Expert Rev Anticancer Ther. 2018;18:719-722.
    PubMed     Text format    

    Front Oncol

  23. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting.
    Front Oncol. 2019;8:642.
    PubMed     Text format     Abstract available


  24. SAFWAT O, Abd-Ellatif RN, Othman TS, Afifi M, et al
    The evolving role of protein disulfide isomerase A3 in Egyptian bladder cancer patients.
    Gene. 2019 Jan 29. pii: S0378-1119(19)30068-X. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  25. DI Y, Chen D, Yu W, Yan L, et al
    Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis.
    Hereditas. 2019;156:7.
    PubMed     Text format     Abstract available

    Indian J Pathol Microbiol

  26. ELKADY N, Sultan M, Elkhouly E
    Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance.
    Indian J Pathol Microbiol. 2018;61:526-531.
    PubMed     Text format     Abstract available

    Int Urol Nephrol

  27. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    PubMed     Text format     Abstract available

    J Adv Pract Oncol

  28. LEMKE EA, Shah AY
    Management of Advanced Bladder Cancer: An Update.
    J Adv Pract Oncol. 2018;9:410-416.
    PubMed     Text format     Abstract available

    J BUON

  29. BOC A, Crisan N, Vesa SC, Coman I, et al
    The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer.
    J BUON. 2018;23:104-110.
    PubMed     Text format     Abstract available

    J Cancer

  30. XU C, Zhou J, Wang Y, Wang A, et al
    Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7.
    J Cancer. 2019;10:539-546.
    PubMed     Text format     Abstract available

    J Gastrointest Surg

  31. KATTEPUR AK, Patkar S, Goel M, Ramaswamy A, et al
    Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
    J Gastrointest Surg. 2019 Jan 31. pii: 10.1007/s11605-019-04104.
    PubMed     Text format     Abstract available

    J Hand Surg Am

  32. JORGENSEN MS, Oldenburg WA, Murray PM
    Mycotic Aneurysm of the Ulnar Artery Secondary to Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Rare Presentation of Hypothenar Hammer Syndrome.
    J Hand Surg Am. 2019 Feb 4. pii: S0363-5023(18)31479.
    PubMed     Text format     Abstract available

    J Pathol

  33. HEIDE T, Maurer A, Eipel M, Knoll K, et al
    Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    J Pathol. 2019 Feb 4. doi: 10.1002/path.5250.
    PubMed     Text format     Abstract available

    J Trace Elem Med Biol

  34. SOUKUPOVA K, Rudolf E
    Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells.
    J Trace Elem Med Biol. 2019;52:58-67.
    PubMed     Text format     Abstract available

    J Urol

  35. WANG DS
    Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer.
    J Urol. 2019 Feb 1. doi: 10.1097/JU.0000000000000154.
    PubMed     Text format    

    JNCI Cancer Spectr

  36. MARQUEEN KE, Waingankar N, Sfakianos JP, Mehrazin R, et al
    Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States.
    JNCI Cancer Spectr. 2018;2:pky075.
    PubMed     Text format     Abstract available

    Nat Rev Urol

  37. BURKHARD FC, Thalmann GN
    No survival benefit with extended lymphadenectomy: now what?
    Nat Rev Urol. 2019;16:3-4.
    PubMed     Text format     Abstract available

    Oncol Lett

  38. CHEN Y, Liu L, Guo Z, Wang Y, et al
    Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Oncol Lett. 2019;17:2047-2056.
    PubMed     Text format     Abstract available


  39. OSTERMAN CK, Babu DS, Geynisman DM, Lewis B, et al
    Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
    Oncologist. 2019 Feb 6. pii: theoncologist.2018-0561.
    PubMed     Text format     Abstract available

    Pathol Int

  40. ISHII A, Tei Y, Murakami T, Notohara K, et al
    An unusual case of Abeta2M amyloid deposition in bladder cancer in a non-dialysis patient.
    Pathol Int. 2019 Feb 1. doi: 10.1111/pin.12770.
    PubMed     Text format     Abstract available

    Pract Radiat Oncol

  41. ADIL K, Popovic M, Cury FL, Faria SL, et al
    Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy.
    Pract Radiat Oncol. 2019;9:24-28.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  42. LIM YW, Chen-Harris H, Mayba O, Lianoglou S, et al
    Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
    Proc Natl Acad Sci U S A. 2018;115:E11701-E11710.
    PubMed     Text format     Abstract available

    Scand J Urol

    Editorial comment on: The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Feb 4:1-2. doi: 10.1080/21681805.2018.1563629.
    PubMed     Text format    

    Sci Rep

  44. YANG X, Zhao L, Zhang T, Xi J, et al
    Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells.
    Sci Rep. 2019;9:1048.
    PubMed     Text format     Abstract available

    Ther Adv Urol

  45. MARCQ G, Jarry E, Ouzaid I, Hermieu JF, et al
    Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823678.
    PubMed     Text format     Abstract available

  46. RAO A, Patel MR
    A review of avelumab in locally advanced and metastatic bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823485.
    PubMed     Text format     Abstract available

    Urol Oncol

  47. MATULAY JT, Woldu SL, Lim A, Narayan VM, et al
    The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 28. pii: S1078-1439(19)30021.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.